Antonio Migliarese - 28 Nov 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
CFO
Signature
/s/ Antonio Migliarese
Issuer symbol
CYDY
Transactions as of
28 Nov 2022
Net transactions value
$0
Form type
4
Filing time
30 Nov 2022, 19:34:42 UTC
Previous filing
17 Nov 2022
Next filing
05 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYDY Common Stock Award $0 +12,008 +7% $0.000000 183,207 30 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Award $0 +4,585,536 $0.000000 4,585,536 28 Nov 2022 Common Stock 4,585,536 $0.3500 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.
F2 477,660 shares vested on November 28, 2022; the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) from November 2022 through May 2026.